How Europe could have more Biotech Champions like argenx
For decades, the narrative of European biotech has been one of “innovation flight”: brilliant science...
Sander Slootweg, Forbion 🇳🇱 | European Biotech Investment, Venture Capital | E56
Forbion celebrates its 20th anniversary this year, with a whopping €5 billion raised so far....
Baker Brothers Investing Secrets: Lessons from One of Biotech’s Most Successful and Private Backers
In a biotech landscape dominated by hype and volatility, the Baker Brothers have emerged as...
Never Miss a New Episode 💌
Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.
Watch & Subscribe
